MDS evidence-based review of treatments for essential tremor.
Joaquim J FerreiraTiago A MestreKelly E LyonsJulián Benito-LeónEng-King TanGiovanni AbbruzzeseMark HallettDietrich HaubenbergerRodger ElbleGuenther Deuschlnull nullPublished in: Movement disorders : official journal of the Movement Disorder Society (2019)
Propranolol, primidone, and topiramate (>200 mg/day) are the pharmacological interventions in which the data reviewed robustly supported efficacy. Their safety profile and patient preference may guide the prioritization of these interventions in clinical practice. MRI-guided focused ultrasound thalamotomy was, for the first time, assessed and was considered to be possibly useful. There is a need to improve study design in essential tremor and overcome the limitation of small sample sizes, cross-over studies, short-term follow-up studies, and use of nonvalidated clinical scales. © 2019 International Parkinson and Movement Disorder Society.